NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides Physician Tablet, Patient Data Management System, and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Neuropace Inc.

Neuropace, Inc. ( ($NPCE) ) has released its Q3 earnings. Here is a breakdown of the information Neuropace, Inc. presented to its investors. NeuroP...

NeuroPace Reports Record Revenue and Raises Guidance

Neuropace, Inc. (($NPCE)) announced an update on their ongoing clinical study. Study Overview: The RNS System LGS Feasibility Study, officially tit...

Current Yield	N/A	Payout Ratio	N/A
Annual DPS	$0.00	Growth Streak	0 years
Ex-Dividend	Invalid Date	Pay Date	Invalid Date
Frequency	NA	Quarterly Est	$0.00

	A	B	C	D
1	Symbol	Price	Change	Volume
2	NPCE	$14.35	+6.30%	270.26K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	NPCE	$14.35	+6.3%	270.26K
3
4
5
6

NPCE

NPCE

Dividend Overview

Get Neuropace Inc. Data in Excel

Get Neuropace Inc. Data in Excel